MILLENNIUM MANAGEMENT LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$14,657,379
+36.5%
4,094,240
+40.7%
0.01%
+40.0%
Q2 2023$10,738,586
+60276.6%
2,910,186
-45.8%
0.01%
-50.0%
Q1 2023$17,786
-13.5%
5,373,501
+1.4%
0.01%
-9.1%
Q4 2022$20,552
-99.5%
5,296,781
+206.7%
0.01%
+450.0%
Q3 2022$4,197,000
-64.0%
1,727,003
-70.7%
0.00%
-71.4%
Q2 2022$11,662,000
+89.7%
5,889,971
+75.4%
0.01%
+133.3%
Q1 2022$6,146,000
+2471.5%
3,358,699
+1885.1%
0.00%
Q4 2021$239,000
-63.6%
169,198
-70.9%
0.00%
Q3 2021$657,000
-59.0%
581,617
-42.0%
0.00%
-100.0%
Q2 2021$1,603,000
+1471.6%
1,002,136
+1817.4%
0.00%
Q4 2020$102,000
+34.2%
52,264
+64.6%
0.00%
Q3 2020$76,000
-92.0%
31,747
-90.2%
0.00%
-100.0%
Q2 2020$946,000
+69.2%
322,827
+66.3%
0.00%0.0%
Q1 2020$559,000
-47.5%
194,102
-27.1%
0.00%0.0%
Q4 2019$1,064,000
-72.3%
266,101
-69.1%
0.00%
-83.3%
Q3 2019$3,838,000
+732.5%
862,519
+624.7%
0.01%
+500.0%
Q2 2019$461,000
-55.5%
119,013
-48.1%
0.00%0.0%
Q2 2018$1,035,000
-17.8%
229,416
-16.2%
0.00%
-50.0%
Q1 2018$1,259,000
+480.2%
273,621
+305.2%
0.00%
Q4 2017$217,000
+267.8%
67,533
+254.0%
0.00%
Q3 2017$59,00019,0780.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aisling Capital LLC 3,608,171$8,624,0002.44%
Broadfin Capital, LLC 4,226,077$10,100,0001.33%
MORGENS WATERFALL VINTIADIS & CO INC 400,000$956,0000.85%
Consonance Capital Management LP 4,588,352$10,966,0000.81%
Perceptive Advisors 6,521,102$14,542,0000.55%
Diag Capital Management, LP 182,100$435,0000.50%
683 Capital Management, LLC 805,000$1,924,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$120,0000.03%
AVANTAX ADVISORY SERVICES, INC. 65,050$156,0000.03%
PURA VIDA INVESTMENTS, LLC 37,170$89,0000.02%
View complete list of ADMA BIOLOGICS INC shareholders